Richard W. Griffiths

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

Richard W. Griffiths, Eyad Elkord, David E. Gilham et al. · Cancer Immunology Immunotherapy · 2007 · 196 citations · Full text

Life Sciences, Immunology, Oncology +14

CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations

Enriqueta Felip, Andrea Ardizzoni, Tudor–Eliade Ciuleanu et al. · European Journal of Cancer · 2020 · 162 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision

Richard W. Griffiths · British Journal of Plastic Surgery · 1999 · 140 citations · Full text

Medicine, Dermatology, Surgery +12

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Edurne Arriola, Matthew Wheater, Ian Galea et al. · Journal of Thoracic Oncology · 2016 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Do basal cell carcinomas recur after complete conventional surgical excision?

Richard W. Griffiths, S K Suvarna, Jason Stone · British Journal of Plastic Surgery · 2005 · 110 citations · Full text

Medicine, Dermatology, Surgery +17